Labcorp appoints Victor Bulto, President, U.S. of Novartis, to its Board of Directors.
Bulto brings global healthcare leadership and growth track record to support Labcorp's long-term strategy.
Victor Bulto's extensive experience in healthcare and pharmaceuticals will bolster Labcorp's board.
Labcorp focuses on long-term growth through innovation and global healthcare leadership.
Victor Bulto Appointed
Victor Bulto, a seasoned pharmaceutical executive from Novartis, joins Labcorp's Board of Directors.
Bulto's Expertise
Bulto brings 25 years of experience and proven leadership in healthcare innovation.
Labcorp's Strategy
Labcorp aims to advance strategic priorities with a focus on science and technology innovation.
- Victor Bulto's appointment signals Labcorp's commitment to industry growth and medical advancement.
- Labcorp seeks to accelerate access to novel therapies and shape the future of healthcare through precision medicine.
Victor Bulto's addition to Labcorp's board enhances its expertise and strengthens the company's position in the healthcare industry.